Skip to main content
. 2021 Feb 15;19:48. doi: 10.1186/s12951-021-00789-5

Table 2.

The MBC (µg/ml) of ciprofloxacin in free form and nanostructured lipid carriers in the presence or absence of rolipram against MRSA

Formulation MBC (µg/ml)
Ciprofloxacin in free form 0.98
Ciprofloxacin + rolipram 7.81
Ciprofloxacin in NLCs 0.98‒1.95
Ciprofloxacin + rolipram in NLCs 7.81

Each value represents the mean ± SEM (n = 3)